SipNose Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
SipNose General Information
Description
Developer of intranasal drug delivery devices designed to improve drug efficacy, patient compliance, and safety through non-invasive nose-to-brain drug delivery. The company offers single-use, multi-dose, and reusable devices tailored for daily or emergency use in clinical or home settings, enabling patients to administer medications efficiently with consistent dosing, improving treatment outcomes without invasive procedures.
Contact Information
Website
www.sipnose.com(Operating Subsidiary)
Corporate Office
- 13 Hayetzira Street
- Yokneam 2066720
- Israel
Corporate Office
- 13 Hayetzira Street
- Yokneam 2066720
- Israel
SipNose Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 16-Sep-2024 | Completed | Generating Revenue | |||
| 1. Angel (individual) | Completed | Generating Revenue |
SipNose Patents
SipNose Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022101850-A1 | Devices and methods for delivering a substance to a body cavity | Inactive | 14-Nov-2020 | ||
| WO-2022101851-A1 | Devices and methods for delivering a substance to a body cavity | Inactive | 14-Nov-2020 | ||
| WO-2021260631-A1 | Devices and methods for delivering a substance to a body cavity utilizing blow-fill-seal technology | Inactive | 25-Jun-2020 | ||
| WO-2021245605-A1 | Drug delivery devices and methods for administering substances to a body cavity by heterogenous aerosolization for treatment of binge-eating disorders and/or obesity | Inactive | 04-Jun-2020 | ||
| WO-2021176402-A1 | Devices and methods for delivering a substance to a body cavity | Inactive | 05-Mar-2020 | A61M11/007 |
SipNose Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Angel (individual) | Minority | |||
| Angel (individual) | Minority | |||
| Angel (individual) | Minority |
SipNose FAQs
-
When was SipNose founded?
SipNose was founded in 2011.
-
Where is SipNose headquartered?
SipNose is headquartered in Yokneam, Israel.
-
What industry is SipNose in?
SipNose’s primary industry is Drug Delivery.
-
Is SipNose a private or public company?
SipNose is a Private company.
-
What is SipNose’s current revenue?
The current revenue for SipNose is .
-
Who are SipNose’s investors?
, , and have invested in SipNose.
-
When was SipNose acquired?
SipNose was acquired on 16-Sep-2024.
-
Who acquired SipNose?
SipNose was acquired by AptarGroup.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process